Quality-Adjusted Life Years

"Quality-Adjusted Life Years" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A measurement index derived from a modification of standard life-table procedures and designed to take account of the quality as well as the duration of survival. This index can be used in assessing the outcome of health care procedures or services. (BIOETHICS Thesaurus, 1994)

Descriptor ID	D019057
MeSH Number(s)	E05.318.740.100.500.700 N01.224.935.530.700
Concept/Terms	Quality-Adjusted Life Years Quality-Adjusted Life Years Life Year, Quality-Adjusted Life Years, Quality-Adjusted Quality-Adjusted Life Year Year, Quality-Adjusted Life Years, Quality-Adjusted Life Quality Adjusted Life Years QALY Healthy Years Equivalents Healthy Years Equivalents Equivalents, Healthy Years Healthy Years Equivalent Adjusted Life Years Adjusted Life Years Adjusted Life Year Life Year, Adjusted Life Years, Adjusted Year, Adjusted Life Years, Adjusted Life

Below are MeSH descriptors whose meaning is more general than "Quality-Adjusted Life Years".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Statistics as Topic [E05.318.740]
Actuarial Analysis [E05.318.740.100]
Life Tables [E05.318.740.100.500]
Quality-Adjusted Life Years [E05.318.740.100.500.700]
Health Care [N]
Population Characteristics [N01]
Demography [N01.224]
Vital Statistics [N01.224.935]
Life Tables [N01.224.935.530]
Quality-Adjusted Life Years [N01.224.935.530.700]

Below are MeSH descriptors whose meaning is related to "Quality-Adjusted Life Years".

Below are MeSH descriptors whose meaning is more specific than "Quality-Adjusted Life Years".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Quality-Adjusted Life Years" by people in this website by year, and whether "Quality-Adjusted Life Years" was a major or minor topic of these publications.

Bar chart showing 63 publications over 17 distinct years, with a maximum of 9 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	1	2
2005	0	1	1
2010	0	1	1
2011	0	3	3
2012	1	3	4
2013	1	2	3
2014	1	8	9
2015	0	3	3
2016	0	6	6
2017	0	3	3
2019	1	3	4
2020	0	6	6
2021	0	5	5
2022	0	1	1
2023	0	5	5
2025	0	2	2
2026	0	5	5

Below are the most recent publications written about "Quality-Adjusted Life Years" by people in Profiles.

Findlay MC, Gandhoke GS, Davies JM, Knopman J, Smith KJ, Mokin M, Hassan AE, Harbaugh RE, Khalessi A, Fiehler J, Gross BA, Tarpley JW, Sivakumar W, Bain M, Crowley RW, Link TW, Fraser JF, Levitt MR, Chen PR, Hanel RA, Bernard JD, Jumaa M, Youssef P, Cress MC, Chaudry MI, Shakir HJ, Lesley WS, Billingsley J, Jones JG, Koch MJ, Paul AR, Mack WJ, Osbun JW, Dlouhy K, Grossberg JA, Kellner CP, Sahlein DH, Santarelli J, Schirmer CM, Liu JJ, Majjhoo AQ, Wolfe T, Patel NV, Roark C, Siddiqui AH, Grandhi R. Cost-Effectiveness of Adjunctive Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Secondary Analysis of EMBOLISE. AJNR Am J Neuroradiol. 2026 Oct 01; 47(10):2500-2509.

View in: PubMed
Reynolds MR, Pollit V, Schwamm L, Witte KK, Yaghi S, Rose DZ, Cudworth S, Carpenter J, Rosemas SC, Ziegler PD, Neisen K, Franco NC, Bernstein RA. Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA. BMJ Open. 2026 Apr 27; 16(4):e103766.

View in: PubMed
Joshi M, Kim K, Pickard AS, Sharp LK, Gerber BS, Touchette DR. Long-term cost-effectiveness of a mobile health intervention delivered by clinical pharmacists and community health workers for type 2 diabetes management in urban African American and Latinx populations. Am J Health Syst Pharm. 2026 04 07; 83(8):423-435.

View in: PubMed
Toan ATN, Phung TL, Tran-Duy A, Minh HV. Cost-Effectiveness of Add-On Ivabradine Versus Standard Pharmacotherapy in the Treatment of Heart Failure in Vietnam: An Analysis From a Health System Perspective. Value Health Reg Issues. 2026 Sep; 55:101594.

View in: PubMed
Généreux P, Reynolds MR, Kelley MA, Thompson C, Baron SJ. Cost-Effectiveness of TAVR Compared With Clinical Surveillance in Patients with Asymptomatic Severe Aortic Stenosis in the United States. Value Health. 2026 Jul; 29(7):1171-1179.

View in: PubMed
Choi SE, Simon L. Projected Outcomes of Removing Fluoride From US Public Water Systems. JAMA Health Forum. 2025 05 02; 6(5):e251166.

View in: PubMed
Socolovsky C, Louisias M, Alsulami S, Petty CR, Trivedi M, Lai PS, Cunningham A, Gaffin J, Thorne P, Coull B, Koutrakis P, Baccarelli A, Gold DR, Adamkiewicz G, Permaul P, Banzon T, Hauptman M, Bartnikas LM, Baxi S, Sheehan WJ, Phipatanakul W, Samnaliev M. Cost-effectiveness of school integrated pest management and air filtration in students with asthma. Allergy Asthma Proc. 2025 05 01; 46(3):257-266.

View in: PubMed
Usta G, Ramsey DJ. Low Vision Services Are Underutilized by Patients with Vision Loss from Corneal Disease. Cornea. 2026 Apr 01; 45(4):421-427.

View in: PubMed
Chatterjee A, Stewart EA, Assoumou SA, Chrysanthopoulou SA, Zwick H, Harris RA, O'Dea R, Schackman BR, White LF, Linas BP. Health and Economic Outcomes of Offering Buprenorphine in Homeless Shelters in Massachusetts. JAMA Netw Open. 2024 10 01; 7(10):e2437233.

View in: PubMed
O'Callaghan L, Chertavian E, Johnson SJ, Ferries E, Deligiannidis KM. The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States. J Med Econ. 2024 Jan-Dec; 27(1):492-505.

View in: PubMed

People

Explore

Similar Concepts

Top Journals